New platform of excellence for state-of-the-art proteomics
22 May 2014 | A region on the move, Health Nutrition
A scant 18 months after winning "Laboratory of excellence" status from the French government, ParaFrap, the Lille-based alliance for parasitology and healthcare founded by the local Pasteur Institute, now boasts a fully operational technology platform dedicated to research in proteomics and modified peptides.
P3M offers new prospects for developing vaccines and drugs to control the growing epidemic.
High-performance equipment for first-rate expertise
Based at Lille’s Pasteur Institute, P3M offers users cutting-edge technology plus the highly specialized skills needed to analyze parasitic proteomes.
While the technique is not new, this is the only dedicated platform of its kind in France. Even today, proteomes are poorly understood and scientists lack the basic knowledge that would enable them to develop new vaccines and treatments for these parasitic diseases.
A unique platform serving the entire scientific community
Facilities will be available to other LabEx members, as well as research teams working at the Pasteur Institute on cancer, Alzheimer's disease and metabolic diseases, and at the Lille Infection and Immunity Centre. Services offered by the platform can be accessed by researchers in the region, in France and across Europe. Partnerships with industrial firms and private biotechnology companies should speed up the development of new classes of vaccines and drugs.
Source: Pasteur Institute, Lille